AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $682,196 | -18.9% | 9,761 | -16.6% | 0.00% | -50.0% |
| Q2 2023 | $841,265 | +54.6% | 11,707 | +32.7% | 0.00% | +100.0% |
| Q1 2023 | $544,326 | -18.7% | 8,825 | +1.7% | 0.00% | -50.0% |
| Q4 2022 | $669,257 | +27.2% | 8,677 | -26.4% | 0.00% | +100.0% |
| Q3 2022 | $526,000 | +141.3% | 11,785 | +106.9% | 0.00% | – |
| Q2 2022 | $218,000 | -60.5% | 5,696 | -15.9% | 0.00% | -100.0% |
| Q4 2020 | $552,000 | -44.7% | 6,774 | -51.6% | 0.00% | -50.0% |
| Q3 2020 | $998,000 | -31.7% | 14,005 | -21.1% | 0.00% | 0.0% |
| Q2 2020 | $1,461,000 | +16.1% | 17,755 | -17.0% | 0.00% | 0.0% |
| Q1 2020 | $1,258,000 | -56.3% | 21,385 | -23.3% | 0.00% | -33.3% |
| Q4 2019 | $2,880,000 | +627.3% | 27,865 | +42.3% | 0.00% | – |
| Q3 2019 | $396,000 | – | 19,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |